Alembic Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ALEMBIC, and what generic and branded alternatives to ALEMBIC drugs are available?
ALEMBIC has one hundred and seventy-four approved drugs.
There are eleven tentative approvals on ALEMBIC drugs.
Summary for Alembic
US Patents: | 0 |
Tradenames: | 136 |
Ingredients: | 135 |
NDAs: | 174 |
Patent Litigation for Alembic: | See patent lawsuits for Alembic |
PTAB Cases with Alembic as petitioner: | See PTAB cases with Alembic as petitioner |
Drugs and US Patents for Alembic
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alembic | PRAMIPEXOLE DIHYDROCHLORIDE | pramipexole dihydrochloride | TABLET, EXTENDED RELEASE;ORAL | 204518-004 | Jan 2, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Alembic Pharms Ltd | IRBESARTAN | irbesartan | TABLET;ORAL | 091236-002 | Oct 15, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Alembic | ARIPIPRAZOLE | aripiprazole | TABLET;ORAL | 202101-005 | Apr 28, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.